Rol de la vitamina D en la encefalopatía hipóxica isquémica

Bibliografía

1 Kumar J, Muntner P, Kaskel F, Hailpern S, Melamed M: Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004. Pediatrics 2009; 124:e362–e370.

2 Wagner C, Greer F; American Academy of Pediatrics Section on Breastfeeding; American Academy of Pediatrics Committee on Nutrition: Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142–1152.

3 Hanson C, Armas L, Lyden E, Anderson-Berry A: Vitamin D status and associations in newborn formula-fed infants during initial hospitalization. J Am Diet Assoc 2011;111: 1836–1843.

4 Saraf R, Morton S, Camargo C, Grant C: Global summary of maternal and newborn vitamin D status – a systematic review. Matern Child Nutr 2016;12:647–668.

5 Fouda MA, Turkestani IZ, Almusharraf S, AlAjlan A, Angkaya-Bagayawa FF, Sabico S, Mohammed AG, Hassanato R, Al-Serehi A, Alshingetti NM, Al-Daghri NM: Extremely high prevalence of maternal and neonatal vitamin D deficiency in the Arab population. Neonatology 2017;112:225–230.

6 Zehnder D, Bland R, Williams M, McNinch R, Howie A, Stewart P, Hewison M: Extrarenal expression of 25-hydroxyvitamin D3-1αhydroxylase. J Clin Endocrinol Metab 2001; 86:888–894.

7 Eyles D, Smith S, Kinobe R, Hewison M, McGrath J: Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroanat 2005;29:21–30.

8 Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, Nakamichi N, Yoneda Y: Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006;83:1179–1189.

9 Alfieri D, Lehmann M, Oliveira S, Flauzino T, Delongui F, Araújo M, Dichi I, Delfino V, Mezzaroba L, Simão A, Reiche E: Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein, and short-term outcome. Metab Brain Dis 2017;32:493–502.

10 Zhang Y, Leung D, Richers B, Liu Y, Remigio L, Riches D, Goleva E: Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012;188:2127–2135.

11 Penna G, Roncari A, Amuchastegui S, Daniel K, Berti E, Colonna M, Adorini L: Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005;106:3490–3497.

12 Kajta M, Makarewicz D, Zieminska E, Janta D, Domin H, Lason W, Kutner A, Lazarewicz J: Neuroprotection by co-treatment and posttreating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro. Neurochem Int 2009;55:265–274.

13 Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F: Vitamin D3 and brain development. Neuroscience 2003;118:641–653.

14 Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P: 1,25-dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991;28:110– 114.

15 Neveu I, Naveilhan P, Jehan F, Baudet C, Wion D, De Luca H, Brachet P: 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 1994;24: 70–76.

16 Cornet A, Baudet C, Neveu I, Baron-Van Evercooren A, Brachet P, Naveilhan P: 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann Cells in vitro. J Neurosci Res 1998;53:742– 746.

17 Kurinczuk J, White-Koning M, Badawi N: Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010;86:329–338.

18 Mutlu M, Sariaydin M, Aslan Y, Kader S, Dereci S, Kart C, Özer Yaman S, Kural B: Status of vitamin D, antioxidant enzymes, and antioxidant substances in neonates with neonatal hypoxic-ischemic encephalopathy. J Matern Fetal Neonatal Med 2016;29:2259–2263.

19 Lowe D, Hollis B, Wagner C, Bass T, Kaufman D, Horgan M, Givelichian L, Sankaran K, Yager J, Katikaneni L, Wiest D, Jenkins D: Vitamin D insufficiency in neonatal hypoxicischemic encephalopathy. Pediatr Res 2017; 82:55–62.

20 Heaney R, Recker R, Grote J, Horst R, Armas L: Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab 2011; 96:E447–E452.

21 Trang H, Cole D, Rubin L, Pierratos A, Siu S, Vieth R: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998; 68:854–858.

22 Hollis B, Lowery J, Pittard III W, Guy D, Hansen J: Effect of age on the intestinal absorption of vitamin D3-palmitate and nonesterified vitamin D2 in the term human infant. J Clin Endocrinol Metab 1996;81:1385–1388.

23 Chabas J, Stephan D, Marqueste T, Garcia S, Lavaut M, Nguyen C, Legre R, Khrestchatisky M, Decherchi P, Feron F: Cholecalciferol (vitamin D3) improves myelination and recovery after nerve injury. PLoS One 2013;8: E65034.

24 Siafarikas A, Piazena H, Feister U, Bulsara M, Meffert H, Hesse V: Randomised controlled trial analysing supplementation with 250 versus 500 units of vitamin D3, sun exposure and surrounding factors in breastfed infants. Arch Dis Child 2011;96:91–95.

25 Gallo S, Comeau K, Vanstone C, Agellon S, Sharma A, Jones G, L’Abbé M, Khamessan A, Rodd C, Weiler H: Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial. JAMA 2013;309:1785– 1792.

26 Abrams S: Calcium and vitamin D requirements of enterally fed preterm infants. Pediatrics 2013;131:e1676–e1683.

27 Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, et al; ESPGHAN Committee on Nutrition: Enteral Nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010;50:85–91.

28 Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–1930.